Global Graves Disease Market

According to a new report by Univdatos Market Insights, the global graves disease market is expected to reach around USD 965 Million in 2032 by growing at a CAGR of 5%. Among all autoimmune diseases, Graves' disease which develops in the thyroid gland has acquired the status of a global clinical problem. This is a disease that is characterized by an overactivity of the thyroid gland which may cause symptoms such as weight loss, fast heart rate, and lethargy. With the incidence of Graves' disease increasing in populations across the world, the need for its management has never been higher.